An observational study in Acute Coronary Syndrome, Heart Failure and Syncope, sponsored by Cardiologie et Développement. Status unknown at 20 sites in 13 countries. Per ClinicalTrials.gov, last updated 2018-05-25.
Sponsored by Cardiologie et Développement · Observational
FEVRIER study is an observatory of hospitalizations in cardiology units in sub-Saharan Africa.
FEVRIER is an observational study based on a questionnaire completed by investigators for each hospitalization in cardiology unit during the month of February.The investigator is a physician of the participating hospital.
FEVRIER evaluates the modalities of care management. It will take place in cardiology units of hospitals of sub-Saharian countries one month per year (month of February) during 5 years.
The investigator will thoroughly complete:
Patients with at least one day of hospitalization will be enrolled in the study. On the first day of February, all patients already hospitalized will be enrolled and all patients hospitalized in the last day of February will be followed until their discharge. thus, data collection will start 1st day of investigation, during February and will continue until the discharge of the last enrolled patient.
1,488 studies on the registry are indexed under Acute Coronary Syndrome; 273 are open to participants now.
This study's planned enrollment of 5,000 is above the median of 500 across 590 observational studies indexed under Acute Coronary Syndrome.
Browse Acute Coronary Syndrome studies →Cardiologie et Développement is the lead sponsor of 3 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Each patient hospitalized in cardiology unit of participating centers during the month of February can be included.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The study FEVRIER (survey of hospitalizations in cardiology units in sub-Saharan Africa) aims to establish a description of sub-Saharan standard of care, in order to get a cross sectional analysis (globally and per country) and a longitudinal analysis (evolution during 5 years).
Description of patients in cardiology unit in sub-Saharan Africa:socio-demographic characterization
low/medium low / medium high/high
Time frame: 5 years
Description of patients in cardiology unit in sub-Saharan Africa:causes of hospitalization
one answer with main reason for hospitalization
Time frame: 5 years
Description of patients in cardiology unit in sub-Saharan Africa: co-morbidities
cardiovascular risk factors/history of cardiovascular disease/kidney disease/cancer/alcoholism/psychiatric disorder/sickle cell anemia/HIV:Hepatitis/tuberculosis/other
Time frame: 5 years
Description of patients in cardiology unit in sub-Saharan Africa: hospital examinations
blood test/ECG/Chest Xray/Echocardiography/Coronarography/Brain scan
Time frame: 5 years
Description of patients in cardiology unit in sub-Saharan Africa: duration of hospitalization
number of days spent in cardiology departement
Time frame: 5 years
Description of patients in cardiology unit in sub-Saharan Africa: discharge diagnosis
medical conclusion
Time frame: 5 years
number of patients with heart failure
to measure the evolution of the number of patients with heart failure over 5 years
Time frame: 5 years
number of patients with myocardial infarction
to measure the evolution of the number of patients with myocardial infarction over 5 years
Time frame: 5 years
number of patients with atrial fibrillation
to measure the evolution of the number of patients with atrial fibrillation over 5 years
Time frame: 5 years
Plan to share: No
Started Feb 2017 (actual). Primary completion is estimated for Dec 2020, 46 months after the start.
Of 243 non-industry observational studies under Acute Coronary Syndrome, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 71. This study's planned 46 months is above that.
Counting every sponsor, half of 277 studies reached it within 35 months; a quarter within 18 and three quarters within 68.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Cardiologie et Développement